Literature DB >> 16982214

Rheumatoid synovial fluid T cells are sensitive to APO2L/TRAIL.

María José Martínez-Lorenzo1, Alberto Anel, Berta Saez-Gutierrez, María Royo-Cañas, Alberto Bosque, María Angeles Alava, Andrés Piñeiro, Pilar Lasierra, Jaime Asín-Ungría, Luis Larrad.   

Abstract

The infiltration and accumulation of T cells in the rheumatoid arthritis (RA) synovial fluid (SF) are hallmarks of disease. We aimed to assess the functional relevance of FasL and of APO2L/TRAIL in the persistence of T cells in the rheumatoid SF. We have analyzed the expression of the activation markers HLA-DR and CD69 and also of the death receptor Fas/CD95 and death ligands FasL or APO2L/TRAIL in CD3+ lymphocytes from SF of 62 RA patients, together with their sensitivity to anti-Fas mAb or to rAPO2L/TRAIL, using as controls T lymphocytes present in SF of 20 patients with traumatic arthritis. T lymphocytes infiltrated in SF of RA patients have a chronically activated phenotype, but they are resistant to Fas-induced toxicity. However, they are more susceptible to rAPO2L/TRAIL than T cells in the SF of traumatic arthritis patients. In addition, we found very low amounts of bioactive FasL and APO2L/TRAIL associated with exosomes in SF from RA patients as compared with SF from traumatic arthritis patients. The observation on the sensitivity of RA SF T cells to rAPO2L could have therapeutic implications because bioactive APO2L/TRAIL could be beneficial as a RA treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982214     DOI: 10.1016/j.clim.2006.07.007

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  13 in total

1.  An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T-cell activation in inflammatory arthritis.

Authors:  I-Tsu Chyuan; Hwei-Fang Tsai; Hsiu-Jung Liao; Chien-Sheng Wu; Ping-Ning Hsu
Journal:  Cell Mol Immunol       Date:  2017-04-10       Impact factor: 11.530

2.  Immunosuppressive exosomes: a new approach for treating arthritis.

Authors:  Chenjie Yang; Paul D Robbins
Journal:  Int J Rheumatol       Date:  2012-03-06

3.  Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine.

Authors:  Alberto Benito-Martin; Alvaro Conrado Ucero; Irene Zubiri; Maria Posada-Ayala; Beatriz Fernandez-Fernandez; Pablo Cannata-Ortiz; Maria Dolores Sanchez-Nino; Marta Ruiz-Ortega; Jesus Egido; Gloria Alvarez-Llamas; Alberto Ortiz
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

4.  CD4 T-cell transcriptome analysis reveals aberrant regulation of STAT3 and Wnt signaling pathways in rheumatoid arthritis: evidence from a case-control study.

Authors:  Hua Ye; Jing Zhang; Jun Wang; Yanyan Gao; Yan Du; Chun Li; Minghua Deng; Jianping Guo; Zhanguo Li
Journal:  Arthritis Res Ther       Date:  2015-03-22       Impact factor: 5.156

5.  Comparative proteomics of exosomes secreted by tumoral Jurkat T cells and normal human T cell blasts unravels a potential tumorigenic role for valosin-containing protein.

Authors:  Alberto Bosque; Lisa Dietz; Ana Gallego-Lleyda; Manuel Sanclemente; María Iturralde; Javier Naval; María Angeles Alava; Luis Martínez-Lostao; Hermann-Josef Thierse; Alberto Anel
Journal:  Oncotarget       Date:  2016-05-17

6.  Identifying Reliable Diagnostic/Predictive Biomarkers for Rheumatoid Arthritis.

Authors:  Leroy Shervington; Ashish Darekar; Murassa Shaikh; Roshini Mathews; Amal Shervington
Journal:  Biomark Insights       Date:  2018-09-24

Review 7.  Role of Exosomes in the Regulation of T-cell Mediated Immune Responses and in Autoimmune Disease.

Authors:  Alberto Anel; Ana Gallego-Lleyda; Diego de Miguel; Javier Naval; Luis Martínez-Lostao
Journal:  Cells       Date:  2019-02-12       Impact factor: 6.600

8.  Synovial fluid pretreatment with hyaluronidase facilitates isolation of CD44+ extracellular vesicles.

Authors:  Janneke Boere; Chris H A van de Lest; Sten F W M Libregts; Ger J A Arkesteijn; Willie J C Geerts; Esther N M Nolte-'t Hoen; Jos Malda; P René van Weeren; Marca H M Wauben
Journal:  J Extracell Vesicles       Date:  2016-08-09

Review 9.  Review: Novel Insights Into Tumor Necrosis Factor Receptor, Death Receptor 3, and Progranulin Pathways in Arthritis and Bone Remodeling.

Authors:  Anwen Williams; Eddie C Y Wang; Lorenz Thurner; Chuan-Ju Liu
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

Review 10.  Extracellular Vesicles in Joint Disease and Therapy.

Authors:  Janneke Boere; Jos Malda; Chris H A van de Lest; P René van Weeren; Marca H M Wauben
Journal:  Front Immunol       Date:  2018-11-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.